在短期监禁人群中治疗丙型肝炎的可行性。
Feasibility of Treating Hepatitis C in a Transient Jail Population.
作者信息
MacDonald Ross, Akiyama Matthew J, Kopolow Aimee, Rosner Zachary, McGahee Wendy, Joseph Rodrigue, Jaffer Mohamed, Venters Homer
机构信息
Correctional Health Services, New York City Health + Hospitals, Bronx; and.
Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.
出版信息
Open Forum Infect Dis. 2017 Jul 7;4(3):ofx142. doi: 10.1093/ofid/ofx142. eCollection 2017 Summer.
Abstract
Jails represent a critical component of the public health response to HCV elimination. We report on outcomes of 104 patients receiving HCV treatment from January 1, 2014 to June 30, 2016 in a large urban jail setting. Our data demonstrate that treatment in jails is feasible, but many barriers remain.
摘要
监狱是公共卫生应对丙型肝炎病毒消除工作的关键组成部分。我们报告了2014年1月1日至2016年6月30日期间在一个大型城市监狱环境中接受丙型肝炎病毒治疗的104名患者的治疗结果。我们的数据表明，在监狱中进行治疗是可行的，但仍存在许多障碍。
相似文献
1
Feasibility of Treating Hepatitis C in a Transient Jail Population.
Open Forum Infect Dis. 2017 Jul 7;4(3):ofx142. doi: 10.1093/ofid/ofx142. eCollection 2017 Summer.
2
The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014-2017.
EClinicalMedicine. 2020 Oct 5;27:100567. doi: 10.1016/j.eclinm.2020.100567. eCollection 2020 Oct.
3
Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014.
Public Health Rep. 2016 May-Jun;131 Suppl 2(Suppl 2):98-104. doi: 10.1177/00333549161310S215.
4
Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.
Int J Prison Health. 2018 Jun 11;14(2):89-100. doi: 10.1108/IJPH-03-2017-0012.
5
Rapid HIV Screening in an Urban Jail: How Testing at Exit With Linkage to Community Care Can Address Perceived Barriers.
J Prim Prev. 2015 Dec;36(6):427-32. doi: 10.1007/s10935-015-0408-1.
6
The contribution of a urine-based jail screening program to citywide male Chlamydia and gonorrhea case rates in New York City.
Sex Transm Dis. 2009 Feb;36(2 Suppl):S58-61. doi: 10.1097/OLQ.0b013e31815615bb.
7
Hepatitis C Screening of the "Birth Cohort" (Born 1945-1965) and Younger Inmates of New York City Jails.
Am J Public Health. 2016 Jul;106(7):1276-7. doi: 10.2105/AJPH.2016.303163. Epub 2016 May 19.
8
The critical link between health care and jails.
Health Aff (Millwood). 2014 Mar;33(3):443-7. doi: 10.1377/hlthaff.2013.1350.
9
Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.
Curr HIV/AIDS Rep. 2020 Feb;17(1):18-25. doi: 10.1007/s11904-019-00476-z.
10
The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care.
Open Forum Infect Dis. 2015 Nov 12;2(4):ofv168. doi: 10.1093/ofid/ofv168. eCollection 2015 Dec.
引用本文的文献
1
Hepatitis C Testing Protocols Across Massachusetts Jails, 2022-2023: An Opportunity for Intervention.
Public Health Rep. 2025 Jun 16:333549251325067. doi: 10.1177/00333549251325067.
2
Estimates of Hepatitis C Seroprevalence and Viremia in State Prison Populations in the United States.
J Infect Dis. 2023 Sep 13;228(Suppl 3):S160-S167. doi: 10.1093/infdis/jiad227.
3
US Hepatitis C Elimination Plan.
JAMA. 2023 Sep 5;330(9):877-878. doi: 10.1001/jama.2023.11757.
4
Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study.
Life (Basel). 2023 Apr 17;13(4):1033. doi: 10.3390/life13041033.
5
Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be?
Can Liver J. 2019 Dec 10;2(4):171-183. doi: 10.3138/canlivj.2019-0007. eCollection 2019 Fall.
6
The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.
Sci Prog. 2022 Apr-Jun;105(2):368504221105173. doi: 10.1177/00368504221105173.
7
Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.
Public Health Rep. 2023 Mar-Apr;138(2):248-258. doi: 10.1177/00333549221076546. Epub 2022 Mar 3.
8
Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.
Public Health Rep. 2022 Nov-Dec;137(6):1126-1135. doi: 10.1177/00333549211049263. Epub 2021 Oct 25.
9
Management of Hepatitis C in Delaware Prisons: : Approaching Microenvironmental Eradication.
Dela J Public Health. 2019 May 28;5(2):20-27. doi: 10.32481/djph.2019.05.006. eCollection 2019 May.
10
"I'm not gonna be able to do anything about it, then what's the point?": A broad group of stakeholders identify barriers and facilitators to HCV testing in a Massachusetts jail.
PLoS One. 2021 May 26;16(5):e0250901. doi: 10.1371/journal.pone.0250901. eCollection 2021.
本文引用的文献
1
New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners.
Health Aff (Millwood). 2016 Oct 1;35(10):1893-1901. doi: 10.1377/hlthaff.2016.0296.
2
Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
Ann Intern Med. 2016 Jan 19;164(2):84-92. doi: 10.7326/M15-0617. Epub 2015 Nov 24.
3
Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysis.
Ann Intern Med. 2014 Oct 21;161(8):546-53. doi: 10.7326/M14-0602.
4
Responding to hepatitis C through the criminal justice system.
N Engl J Med. 2014 May 15;370(20):1871-4. doi: 10.1056/NEJMp1311941.
5
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
N Engl J Med. 2014 Apr 17;370(16):1483-93. doi: 10.1056/NEJMoa1316366. Epub 2014 Apr 11.
Zotero 插件